Mednax Inc Stock Analysis

MD Stock  USD 14.96  0.19  1.29%   
Mednax Inc is undervalued with Real Value of 15.58 and Target Price of 14.5. The main objective of Mednax stock analysis is to determine its intrinsic value, which is an estimate of what Mednax Inc is worth, separate from its market price. There are two main types of Mednax's stock analysis: fundamental analysis and technical analysis.
The Mednax stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mednax's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Mednax Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mednax Inc has Price/Earnings To Growth (PEG) ratio of 0.88. The entity recorded a loss per share of 2.34. The firm had not issued any dividends in recent years. Mednax had 2:1 split on the 20th of December 2013. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Pediatrix Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 5000 people. To find out more about Mednax Inc contact James MD at 954 384 0175 or learn more at https://www.pediatrix.com.

Mednax Quarterly Total Revenue

511.16 Million

Mednax Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mednax's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mednax Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Mednax Inc appears to be risky and price may revert if volatility continues
The company generated the yearly revenue of 1.99 B. Annual Net Loss to common stockholders was (60.41 M) with gross profit of 467.03 M.
Over 98.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Pediatrix Medical Group Downgraded by StockNews.com to Hold

Mednax Inc Upcoming and Recent Events

16th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
16th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Mednax Largest EPS Surprises

Earnings surprises can significantly impact Mednax's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2001-08-08
2001-06-300.070.080.0114 
2001-05-08
2001-03-310.050.060.0120 
1998-07-30
1998-06-300.10.110.0110 
View All Earnings Estimates

Mednax Environmental, Social, and Governance (ESG) Scores

Mednax's ESG score is a quantitative measure that evaluates Mednax's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Mednax's operations that may have significant financial implications and affect Mednax's stock price as well as guide investors towards more socially responsible investments.

Mednax Thematic Classifications

In addition to having Mednax stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

Mednax Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Amvescap Plc.2024-06-30
1.4 M
Segall Bryant & Hamill2024-09-30
1.2 M
Caspian Capital Partners, L.p.2024-09-30
1.1 M
Citadel Advisors Llc2024-09-30
1.1 M
Jpmorgan Chase & Co2024-06-30
M
Aqr Capital Management Llc2024-06-30
942.4 K
Dana Investment Advisors Inc2024-09-30
915.6 K
Weiss Asset Management Lp2024-09-30
912.8 K
Bank Of America Corp2024-06-30
899.9 K
Blackrock Inc2024-06-30
13.7 M
Vanguard Group Inc2024-09-30
10.7 M
Note, although Mednax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mednax Market Capitalization

The company currently falls under 'Mid-Cap' category with a market capitalization of 1.28 B.

Mednax Profitablity

The company has Net Profit Margin (PM) of (0.13) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.1 %, which signifies that for every $100 of sales, it has a net operating income of $0.1.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.07)(0.07)
Return On Assets(0.03)(0.03)
Return On Equity(0.07)(0.07)

Management Efficiency

Mednax Inc has Return on Asset (ROA) of 0.0467 % which means that for every $100 of assets, it generated a profit of $0.0467. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.2986) %, which implies that it produced no returns to current stockholders. Mednax's management efficiency ratios could be used to measure how well Mednax manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.07. In addition to that, Return On Capital Employed is expected to decline to 0. At present, Mednax's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 86.3 M, whereas Other Assets are forecasted to decline to about 212.4 M.
Last ReportedProjected for Next Year
Book Value Per Share 10.11  9.67 
Tangible Book Value Per Share(6.62)(6.95)
Enterprise Value Over EBITDA 47.17  49.53 
Price Book Value Ratio 0.92  0.87 
Enterprise Value Multiple 47.17  49.53 
Price Fair Value 0.92  0.87 
Enterprise Value1.3 B1.2 B
Management at Mednax Inc focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Operating Margin
0.1026
Profit Margin
(0.13)
Beta
1.555
Return On Assets
0.0467
Return On Equity
(0.30)

Technical Drivers

As of the 1st of December, Mednax secures the Risk Adjusted Performance of 0.1205, mean deviation of 1.95, and Downside Deviation of 1.84. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mednax Inc, as well as the relationship between them. Please verify Mednax Inc treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mednax Inc is priced some-what accurately, providing market reflects its recent price of 14.96 per share. Given that Mednax Inc has jensen alpha of 0.3028, we recommend you to check Mednax's last-minute market performance to make sure the company can sustain itself at a future point.

Mednax Inc Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mednax middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mednax Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Mednax Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mednax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mednax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mednax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Mednax Outstanding Bonds

Mednax issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mednax Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mednax bonds can be classified according to their maturity, which is the date when Mednax Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Mednax Predictive Daily Indicators

Mednax intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mednax stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mednax Corporate Filings

F4
14th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
13th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F4
12th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
1st of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
31st of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F3
4th of October 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
F4
3rd of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
29th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Mednax Forecast Models

Mednax's time-series forecasting models are one of many Mednax's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mednax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Mednax Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mednax prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mednax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mednax. By using and applying Mednax Stock analysis, traders can create a robust methodology for identifying Mednax entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.02)(0.02)
Net Loss(0.03)(0.03)
Gross Profit Margin 0.21  0.20 

Current Mednax Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mednax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mednax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
14.5Buy7Odds
Mednax Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mednax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mednax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mednax Inc, talking to its executives and customers, or listening to Mednax conference calls.
Mednax Analyst Advice Details

Mednax Stock Analysis Indicators

Mednax Inc stock analysis indicators help investors evaluate how Mednax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mednax shares will generate the highest return on investment. By understating and applying Mednax stock analysis, traders can identify Mednax position entry and exit signals to maximize returns.
Begin Period Cash Flow9.8 M
Long Term Debt611.6 M
Common Stock Shares Outstanding82.2 M
Total Stockholder Equity849.1 M
Tax Provision12 M
Quarterly Earnings Growth Y O Y-0.112
Property Plant And Equipment Net145.9 M
Cash And Short Term Investments177.7 M
Cash73.3 M
Accounts Payable34.6 M
Net Debt628.4 M
50 Day M A13.2514
Total Current Liabilities388.9 M
Other Operating ExpensesB
Non Current Assets Total1.7 B
Forward Price Earnings9.6618
Non Currrent Assets Other82.2 M
Stock Based Compensation12.3 M

Complementary Tools for Mednax Stock analysis

When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world